NCAM1 and Alzheimer disease: Together, these data support a novel mechanistic pathway through which PSA-NCAM suppresses the ES-GluN2B shift and promotes synaptic anchoring, thereby preserving plasticity and mitigating excitotoxic risk in the context of AD.